Search Results 1251-1260 of 16938 for monoclonal antibody

1. Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer - Mayo Clinic

   * Patients with prior hypersensitivity to monoclonal antibodies (mAb) * Women who are pregnant or breastfeeding * Patients who received prior treatment with ...

2. Anand Padmanabhan, M.B.B.S., Ph.D. - Doctors and Medical Staff - Mayo Clinic

   ... (monoclonal gammopathy of thrombotic/thrombocytopenic significance). ... MemberThe Antibody Society. 2021 - present. FacultyDLMP Research Strategy: Mentoring ...

3. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

   ... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. Participation eligibility. Participant eligibility ...

4. Publications - Timothy D. Wiltshire, Ph.D. - Mayo Clinic

   Antibodies as drugs-a Keystone Symposia report. ... Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants ...

5. CTX131 in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Concurrent systemic treatment with an anticancer biologic (e.g., monoclonal antibody) within 30 days prior to CTX131 infusion or with a non-biological ...

6. Novel Study Interventions and Combinations in Participants with Colorectal Cancer - Mayo Clinic

   Known history of severe allergy to any monoclonal antibody or study ... antibodies. Active or uncontrolled hepatitis B or hepatitis C; Participants are ...

7. A Study to Evaluate the Safety and Effectiveness of AB928-Based Treatment Combinations to Treat Patients with Metastatic Colorectal Cancer - Mayo Clinic

   antibody syndrome, Wegener granulomatosis, Sjögren syndrome, Guillain Barré syndrome, or multiple sclerosis - Exclusion Criteria for Cohorts A and B ...

8. A Study to Evaluate Induction Chemotherapy with ABVD Followed by Brentuximab Vedotin Consolidation in Previously-untreated, Non-bulky Stage I or II Hodgkin Lymphoma - Mayo Clinic

   For this research study, the use of brentuximab vedotin in newly diagnosed Hodgkin lymphoma is considered investigational. Brentuximab vedotin is an antibody ...

9. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   Exception: Monoclonal and bispecific antibodies is acceptable. Prior therapy with golcadomide ≤4 weeks prior to Registration. Prior autologous SCT ≤3 ...

10. Publications - Zach Z. Thompson, M.D. - Mayo Clinic

    Larsen R, Allen S, Thompson TZ, Bollag R, Singh G. Challenges in Interpreting Multiple Monoclonal Bands on Serum Protein Electrophoresis and Serum ...